421 related articles for article (PubMed ID: 7391970)
21. Management of ventricular arrhythmias.
Fogoros RN
Am Fam Physician; 1986 Mar; 33(3):236-46. PubMed ID: 3953344
[No Abstract] [Full Text] [Related]
22. [Experimental and initial clinical experiences with the new class Ib anti-arrhythmia agent barucainide].
Gülker H; Heuer H; Frenking B; Haverkamp W; Hindricks G; Bozek B; Bremkes C; Asche KD; Witthöft D
Z Kardiol; 1988 Sep; 77(9):587-94. PubMed ID: 2461620
[TBL] [Abstract][Full Text] [Related]
23. [Effect of lithium hydroxybutyrate and lithium chloride on heart rhythm disorders of various origins].
Galenko-Iaroshevskiĭ PA; Shadurskiĭ KS; Tikhonov AV
Farmakol Toksikol; 1984; 47(4):54-9. PubMed ID: 6090202
[TBL] [Abstract][Full Text] [Related]
24. Antiarrhythmic effects of proadifen hydrochloride (SKF 525-A).
Viana AP; Osswald W
Arzneimittelforschung; 1970 Jun; 20(6):851-3. PubMed ID: 5468902
[No Abstract] [Full Text] [Related]
25. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
[TBL] [Abstract][Full Text] [Related]
26. Anti-arrhythmic action of dilazep. Action on experimental arrhythmias induced by g-strophanthin (ouabain), epinephrine and aconitine.
Sano N; Kawada M; Fukutomi Y
Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1893-8. PubMed ID: 4141624
[No Abstract] [Full Text] [Related]
27. [The anti-arrhythmia activity and effect on the heart conduction system of the new anti-arrhythmia preparation bonnecor].
Sokolov SF; Golitsyn SP; Malakhov VI; Bankuzov VA; Koltunova MI; Golitsyn LS
Farmakol Toksikol; 1990; 53(3):57-60. PubMed ID: 2387385
[TBL] [Abstract][Full Text] [Related]
28. N-(2,6-Dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate (SUN 1165): a new potent and long-acting antiarrhythmic agent.
Aisaka K; Hidaka T; Inomata N; Hamasaki S; Ishihara T; Morita M
Arzneimittelforschung; 1985; 35(8):1239-45. PubMed ID: 4074441
[TBL] [Abstract][Full Text] [Related]
29. Antiarrhythmic and general cardiovascular activity of the N,N-dimethylquaternary ammonium derivative of bunolol.
Kaplan HR; Barker JW; Dugan D; Fox J; Giardino E
Arch Int Pharmacodyn Ther; 1974 Jan; 207(1):28-43. PubMed ID: 4151048
[No Abstract] [Full Text] [Related]
30. Electrophysiologic, antiarrhythmic and hemodynamic effects of transcainide.
Carmeliet E; Janssen PA; Heykants J; Niemegeers CJ; Remeysen P; Van De Water A; Van Gerven W; Wauquier A; Xhonneux R
Arch Int Pharmacodyn Ther; 1987 Jun; 287(2):272-90. PubMed ID: 3632145
[TBL] [Abstract][Full Text] [Related]
31. [Example of dose finding in practice. Pharmacology of an antiarrhythmic agent (author's transl)].
Oberdorf A; Raschack M
Arzneimittelforschung; 1977 Feb; 27(2A):281-3. PubMed ID: 577176
[TBL] [Abstract][Full Text] [Related]
32. Antiarrhythmic effect of newly synthesized compound 44Bu on model of aconitine-induced arrhythmia -- compared to lidocaine.
Bartosova L; Novak F; Bebarova M; Frydrych M; Brunclik V; Opatrilova R; Kolevska J; Mokry P; Kollar P; Strnadova V; Suchy P
Eur J Pharmacol; 2007 Dec; 575(1-3):127-33. PubMed ID: 17706639
[TBL] [Abstract][Full Text] [Related]
33. Antiarrhythmic activity of the hydrochloride of 1-methoxymethyl-2-(1-perhydroazepinyl)ethyl ester of 2-(n)-pentyloxycarbanilic acid.
Gibala P; Sotníková R; Knezl V; Drímal J
Arzneimittelforschung; 1987 Feb; 37(2):149-52. PubMed ID: 3580018
[TBL] [Abstract][Full Text] [Related]
34. Clinical pharmacology and pharmacokinetics of pirmenol.
Reiter MJ
Angiology; 1988 Mar; 39(3 Pt 2):293-8. PubMed ID: 3281518
[TBL] [Abstract][Full Text] [Related]
35. [Pharmacological study of quaternary trimecaine derivatives].
Gendenshteĭn EI; Tsybusov AP; Zhukauskaĭte LN; Stankevichius AP; Bukauskas FF
Farmakol Toksikol; 1983; 46(4):36-40. PubMed ID: 6617835
[TBL] [Abstract][Full Text] [Related]
36. Drug therapy. Flecainide.
Roden DM; Woosley RL
N Engl J Med; 1986 Jul; 315(1):36-41. PubMed ID: 3520324
[No Abstract] [Full Text] [Related]
37. [Pharmacological research on bonnecor and its metabolites].
Poppe H; Heer S; Barch R
Farmakol Toksikol; 1990; 53(3):46-8. PubMed ID: 2387381
[TBL] [Abstract][Full Text] [Related]
38. [Experimental arrhythmia models. Critical study of correlations with arrhythmias observed in clinical practice].
Dupuis BA; Vincent AC
Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():17-27. PubMed ID: 6803699
[TBL] [Abstract][Full Text] [Related]
39. [The effect of ecdysterone on experimental arrhythmias and changes in the hemodynamics and myocardial contractility induced by coronary artery occlusion].
Kurmukov AG; Ermishina OA
Farmakol Toksikol; 1991; 54(1):27-9. PubMed ID: 1860493
[TBL] [Abstract][Full Text] [Related]
40. [Use of bonnecor in ischemic heart disease].
Gorshkov VA; Nesvetov VN; Chestukhin VV; Narynskiĭ AK; Kesarev GV; Solov'eva FV; Orlov VN; Ianitskaia MV; Solodukhina IS
Sov Med; 1990; (6):72-4. PubMed ID: 2396129
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
